1
|
Klein B, Hartle H, Shrestha M, Zenteno AC, Barros Sierra Cordera D, Nicolás-Carlock JR, Bento AI, Althouse BM, Gutierrez B, Escalera-Zamudio M, Reyes-Sandoval A, Pybus OG, Vespignani A, Díaz-Quiñonez JA, Scarpino SV, Kraemer MUG. Spatial scales of COVID-19 transmission in Mexico. PNAS NEXUS 2024; 3:pgae306. [PMID: 39285936 PMCID: PMC11404565 DOI: 10.1093/pnasnexus/pgae306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/14/2024] [Accepted: 06/22/2024] [Indexed: 09/19/2024]
Abstract
During outbreaks of emerging infectious diseases, internationally connected cities often experience large and early outbreaks, while rural regions follow after some delay. This hierarchical structure of disease spread is influenced primarily by the multiscale structure of human mobility. However, during the COVID-19 epidemic, public health responses typically did not take into consideration the explicit spatial structure of human mobility when designing nonpharmaceutical interventions (NPIs). NPIs were applied primarily at national or regional scales. Here, we use weekly anonymized and aggregated human mobility data and spatially highly resolved data on COVID-19 cases at the municipality level in Mexico to investigate how behavioral changes in response to the pandemic have altered the spatial scales of transmission and interventions during its first wave (March-June 2020). We find that the epidemic dynamics in Mexico were initially driven by exports of COVID-19 cases from Mexico State and Mexico City, where early outbreaks occurred. The mobility network shifted after the implementation of interventions in late March 2020, and the mobility network communities became more disjointed while epidemics in these communities became increasingly synchronized. Our results provide dynamic insights into how to use network science and epidemiological modeling to inform the spatial scale at which interventions are most impactful in mitigating the spread of COVID-19 and infectious diseases in general.
Collapse
Affiliation(s)
- Brennan Klein
- Network Science Institute, Northeastern University, Boston, MA 02115, USA
- Laboratory for the Modeling of Biological & Socio-technical Systems, Northeastern University, Boston, MA 02115, USA
- Institute for Experiential AI, Northeastern University, Boston, MA 02115, USA
| | - Harrison Hartle
- Network Science Institute, Northeastern University, Boston, MA 02115, USA
- Santa Fe Institute, Santa Fe, NM 87501, USA
| | - Munik Shrestha
- Network Science Institute, Northeastern University, Boston, MA 02115, USA
| | - Ana Cecilia Zenteno
- Healthcare Systems Engineering, Massachusetts General Hospital, Boston, MA 02114, USA
| | | | - José R Nicolás-Carlock
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de México, 04510, México
| | - Ana I Bento
- Department of Public and Ecosystem Health, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
| | - Benjamin M Althouse
- Information School, University of Washington, Seattle, WA 98105, USA
- Department of Biology, New Mexico State University, Las Cruces, NM 88003, USA
| | - Bernardo Gutierrez
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito USFQ, Quito 170136, Ecuador
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex), Consejo Nacional de Ciencia y Tecnología, Ciudad de México, 03940, México
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7BN, United Kingdom
| | - Marina Escalera-Zamudio
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Consorcio Mexicano de Vigilancia Genómica (CoViGen-Mex), Consejo Nacional de Ciencia y Tecnología, Ciudad de México, 03940, México
| | - Arturo Reyes-Sandoval
- The Jenner Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
- Instituto Politécnico Nacional, IPN, Ciudad de México, 07738, México
| | - Oliver G Pybus
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7BN, United Kingdom
- Department of Pathobiology and Population Science, Royal Veterinary College, London AL9 7TA, United Kingdom
| | - Alessandro Vespignani
- Network Science Institute, Northeastern University, Boston, MA 02115, USA
- Laboratory for the Modeling of Biological & Socio-technical Systems, Northeastern University, Boston, MA 02115, USA
| | - José Alberto Díaz-Quiñonez
- Health Emergencies Department, Pan American Health Organization, Washington, DC 20037, USA
- Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Pachuca Hgo, 42160, México
| | - Samuel V Scarpino
- Network Science Institute, Northeastern University, Boston, MA 02115, USA
- Institute for Experiential AI, Northeastern University, Boston, MA 02115, USA
- Santa Fe Institute, Santa Fe, NM 87501, USA
| | - Moritz U G Kraemer
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7BN, United Kingdom
| |
Collapse
|
2
|
Gräf T, Martinez AA, Bello G, Dellicour S, Lemey P, Colizza V, Mazzoli M, Poletto C, Cardoso VLO, da Silva AF, Motta FC, Resende PC, Siqueira MM, Franco L, Gresh L, Gabastou JM, Rodriguez A, Vicari A, Aldighieri S, Mendez-Rico J, Leite JA. Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean. Nat Commun 2024; 15:1837. [PMID: 38418815 PMCID: PMC10902334 DOI: 10.1038/s41467-024-46143-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 02/15/2024] [Indexed: 03/02/2024] Open
Abstract
Latin America and Caribbean (LAC) regions were an important epicenter of the COVID-19 pandemic and SARS-CoV-2 evolution. Through the COVID-19 Genomic Surveillance Regional Network (COVIGEN), LAC countries produced an important number of genomic sequencing data that made possible an enhanced SARS-CoV-2 genomic surveillance capacity in the Americas, paving the way for characterization of emerging variants and helping to guide the public health response. In this study we analyzed approximately 300,000 SARS-CoV-2 sequences generated between February 2020 and March 2022 by multiple genomic surveillance efforts in LAC and reconstructed the diffusion patterns of the main variants of concern (VOCs) and of interest (VOIs) possibly originated in the Region. Our phylogenetic analysis revealed that the spread of variants Gamma, Lambda and Mu reflects human mobility patterns due to variations of international air passenger transportation and gradual lifting of social distance measures previously implemented in countries. Our results highlight the potential of genetic data to reconstruct viral spread and unveil preferential routes of viral migrations that are shaped by human mobility patterns.
Collapse
Affiliation(s)
- Tiago Gräf
- Laboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Brazil.
| | - Alexander A Martinez
- Gorgas Memorial Institute for Health Studies, Panama City, Panama
- National Research System (SNI), National Secretary of Research, Technology and Innovation (SENACYT), Panama City, Panama
- Department of Microbiology and Immunology, University of Panama, Panama City, Panama
| | - Gonzalo Bello
- Laboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil
| | - Simon Dellicour
- Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, CP160/12, 50 av. FD Roosevelt, Bruxelles, Belgium
- Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, KU Leuven, University of Leuven, Leuven, Belgium
| | - Philippe Lemey
- Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, KU Leuven, University of Leuven, Leuven, Belgium
| | - Vittoria Colizza
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France
| | - Mattia Mazzoli
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France
| | - Chiara Poletto
- Department of Molecular Medicine, University of Padova, 35121, Padova, Italy
| | - Vanessa Leiko Oikawa Cardoso
- Laboratório de Enfermidades Infecciosas Transmitidas por Vetores, Instituto Gonçalo Moniz, FIOCRUZ-Bahia, Salvador, Brazil
| | | | - Fernando Couto Motta
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
| | - Paola Cristina Resende
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
| | - Marilda M Siqueira
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
| | - Leticia Franco
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA
| | - Lionel Gresh
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA
| | - Jean-Marc Gabastou
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA
| | - Angel Rodriguez
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA
| | - Andrea Vicari
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA
| | - Sylvain Aldighieri
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA
| | - Jairo Mendez-Rico
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA
| | - Juliana Almeida Leite
- Infectious Hazards Management Unit, Health Emergencies Department, Pan American Health Organization, Washington D.C., USA.
| |
Collapse
|
3
|
Flores-Garrido M, de Anda-Jáuregui G, Guzmán P, Meneses-Viveros A, Hernández-Álvarez A, Cruz-Bonilla E, Hernández-Rosales M. Mobility networks in Greater Mexico City. Sci Data 2024; 11:84. [PMID: 38238306 PMCID: PMC10796321 DOI: 10.1038/s41597-023-02880-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Accepted: 12/27/2023] [Indexed: 01/22/2024] Open
Abstract
Based on more than 11 billion geolocated cell phone records from 33 million different devices, daily mobility networks were constructed over a 15-month period for Greater Mexico City, one of the largest and most diverse metropolitan areas globally. The time frame considered spans the entire year of 2020 and the first three months of 2021, enabling the analysis of population movement dynamics before, during, and after the COVID-19 health contingency. The nodes within the 456 networks represent the basic statistical geographic areas (AGEBs) established by the National Institute of Statistics, Geography, and Informatics (INEGI) in Mexico. This framework facilitates the integration of mobility data with numerous indicators provided by INEGI. Edges connecting these nodes represent movement between AGEBs, with edge weights indicating the volume of trips from one AGEB to another. This extensive dataset allows researchers to uncover travel patterns, cross-reference data with socio-economic indicators, and conduct segregation studies, among other potential analyses.
Collapse
Affiliation(s)
- Marisol Flores-Garrido
- Escuela Nacional de Estudios Superiores Unidad Morelia, Universidad Nacional Autónoma de México, Antigua Carretera a Pátzcuaro 8701, Indeco la Huerta, Ciudad de México, 58190, Michoacan, Mexico
| | - Guillermo de Anda-Jáuregui
- National Institute of Genomics Medicine, Periferico Sur 4809, Arenal Tepepan, Tlalpan, 14610, Mexico City, Mexico
- National Council for Science and Technology, Av. Insurgentes Sur 1582, Colonia Crédito Constructor, Benito Juárez, Mexico City, Mexico
| | | | - Amilcar Meneses-Viveros
- Center for Research and Advanced Studies of IPN, Av Instituto Politécnico Nacional 2508, San Pedro Zacatenco, Gustavo A. Madero, 07360, Mexico City, Mexico
| | - Alfredo Hernández-Álvarez
- Center for Genomics Sciences, Universidad Nacional Autónoma de México, Avenida Universidad s/n, Universidad Autonoma del Estado de Morelos, 62210, Cuernavaca, Morelos, Mexico
| | - Erika Cruz-Bonilla
- Center for Research and Advanced Studies of IPN, Irapuato Unit, Libramiento Norte Carretera Irapuato León Kilómetro 9.6, 36821, Irapuato, Guanajuato, Mexico
| | - Maribel Hernández-Rosales
- Center for Research and Advanced Studies of IPN, Irapuato Unit, Libramiento Norte Carretera Irapuato León Kilómetro 9.6, 36821, Irapuato, Guanajuato, Mexico.
| |
Collapse
|
4
|
Gómez-Sánchez I, Castelán-Sánchez HG, Martínez-Castilla LP, Hurtado-Ramírez JM, López-Leal G. Genetic insights into the microevolutionary dynamics and early introductions of human monkeypox virus in Mexico. Arch Virol 2023; 169:2. [PMID: 38070010 DOI: 10.1007/s00705-023-05936-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Accepted: 10/31/2023] [Indexed: 12/18/2023]
Abstract
The recent global outbreak of mpox, caused by monkeypox virus (MPV) emerged in Europe in 2022 and rapidly spread to over 40 countries. The Americas are currently facing the highest impact, reporting over 50,000 cases by early 2023. In this study, we analyzed 880 MPV isolates worldwide to gain insights into the evolutionary patterns and initial introduction events of the virus in Mexico. We found that MPV entered Mexico on multiple occasions, from the United Kingdom, Portugal, and Canada, and subsequently spread locally in different regions of Mexico. Additionally, we show that MPV has an open pangenome, highlighting the role of gene turnover in shaping its genomic diversity, rather than single-nucleotide polymorphisms (SNPs), which do not contribute significantly to genome diversity. Although the genome contains multiple SNPs in coding regions, these remain under purifying selection, suggesting their evolutionary conservation. One notable exception is amino acid position 63 of the protein encoded by the Cop-A4L gene, which is intricately related to viral maturity, which we found to be under strong positive selection. Ancestral state reconstruction indicated that the ancestral state at position 63 corresponds to the amino acid valine, which is present only in isolates of clade I. However, the isolates from the current outbreak contained threonine at position 63. Our findings contribute new information about the evolution of monkeypox virus.
Collapse
Affiliation(s)
- Israel Gómez-Sánchez
- Laboratorio de Biología Computacional y Virómica Integrativa, Centro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico
| | - Hugo G Castelán-Sánchez
- Grupo de Genómica y Dinámica Evolutiva de Microorganismos EmergentesPrograma de Investigadoras e Investigadores por México, Consejo Nacional de Ciencia y Tecnología, Mexico City, Mexico.
| | - León P Martínez-Castilla
- Grupo de Genómica y Dinámica Evolutiva de Microorganismos EmergentesPrograma de Investigadoras e Investigadores por México, Consejo Nacional de Ciencia y Tecnología, Mexico City, Mexico
| | | | - Gamaliel López-Leal
- Laboratorio de Biología Computacional y Virómica Integrativa, Centro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.
| |
Collapse
|
5
|
Taboada BI, Zárate S, García-López R, Muñoz-Medina JE, Gómez-Gil B, Herrera-Estrella A, Sanchez-Flores A, Salas-Lais AG, Roche B, Martínez-Morales G, Domínguez Zárate H, Duque Molina C, Avilés Hernández R, López S, Arias CF. SARS-CoV-2 Omicron variants BA.4 and BA.5 dominated the fifth COVID-19 epidemiological wave in Mexico. Microb Genom 2023; 9:001120. [PMID: 38112714 PMCID: PMC10763511 DOI: 10.1099/mgen.0.001120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 10/09/2023] [Indexed: 12/21/2023] Open
Abstract
In Mexico, the BA.4 and BA.5 Omicron variants dominated the fifth epidemic wave (summer 2022), superseding BA.2, which had circulated during the inter-wave period. The present study uses genome sequencing and statistical and phylogenetic analyses to examine these variants' abundance, distribution, and genetic diversity in Mexico from April to August 2022. Over 35 % of the sequenced genomes in this period corresponded to the BA.2 variant, 8 % to the BA.4 and 56 % to the BA.5 variant. Multiple subvariants were identified, but the most abundant, BA.2.9, BA.2.12.1, BA.5.1, BA.5.2, BA.5.2.1 and BA.4.1, circulated across the entire country, not forming geographical clusters. Contrastingly, other subvariants exhibited a geographically restricted distribution, most notably in the Southeast region, which showed a distinct subvariant dynamic. This study supports previous results showing that this region may be a significant entry point and contributed to introducing and evolving novel variants in Mexico. Furthermore, a differential distribution was observed for certain subvariants among specific States through time, which may have contributed to the overall increased diversity observed during this wave compared to the previous ones. This study highlights the importance of sustaining genomic surveillance to identify novel variants that may impact public health.
Collapse
Affiliation(s)
- Blanca Itzelt Taboada
- Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico
| | - Selene Zárate
- Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City 03100, Mexico
| | - Rodrigo García-López
- Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico
| | - José Esteban Muñoz-Medina
- Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Mexico City 07760, Mexico
| | - Bruno Gómez-Gil
- Centro de Investigación en Alimentación y Desarrollo AC, Coordinación Regional Mazatlán, Acuicultura y Manejo Ambiental, Mazatlan 82100, Mexico
| | - Alfredo Herrera-Estrella
- Laboratorio Nacional de Genómica Para la Biodiversidad-Unidad de Genómica Avanzada, Centro de Investigación y de Estudios Avanzados del IPN, Irapuato 36824, Mexico
| | - Alejandro Sanchez-Flores
- Unidad Universitaria de Secuenciación Masiva y Bioinformática, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico
| | - Angel Gustavo Salas-Lais
- Laboratorio Central de Epidemiología, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico
| | - Benjamin Roche
- Infectious Diseases: Vector, Control, Genetic, Ecology and Evolution (MIVEGEC) Université de Montpellier, IRD, CNRS, 34090 Montpellier, France
| | - Gabriela Martínez-Morales
- Laboratorio Central de Epidemiología, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico
| | - Hermilo Domínguez Zárate
- Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Mexico City 07760, Mexico
| | - Célida Duque Molina
- Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social, Ciudad de México 06700, Mexico
| | - Ricardo Avilés Hernández
- Unidad de Planeación e Innovación en Salud, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico
| | - Susana López
- Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico
| | - Carlos F. Arias
- Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico
| |
Collapse
|